APA (7th ed.) Citation

SJ, K., CW, C., KE, J., WJ, W., J, B., D, G., & S, K. (2022). Follow-up study of infants recruited to the randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants-study protocol for the AZTEC-FU study. Trials, 23(1), 796. https://doi.org/10.1186/s13063-022-06730-x

Chicago Style (17th ed.) Citation

SJ, Kotecha, Course CW, Jones KE, Watkins WJ, Berrington J, Gillespie D, and Kotecha S. "Follow-up Study of Infants Recruited to the Randomised, Placebo-controlled Trial of Azithromycin for the Prevention of Chronic Lung Disease of Prematurity in Preterm Infants-study Protocol for the AZTEC-FU Study." Trials 23, no. 1 (2022): 796. https://doi.org/10.1186/s13063-022-06730-x.

MLA (9th ed.) Citation

SJ, Kotecha, et al. "Follow-up Study of Infants Recruited to the Randomised, Placebo-controlled Trial of Azithromycin for the Prevention of Chronic Lung Disease of Prematurity in Preterm Infants-study Protocol for the AZTEC-FU Study." Trials, vol. 23, no. 1, 2022, p. 796, https://doi.org/10.1186/s13063-022-06730-x.